PGEN
Price
$3.22
Change
-$0.09 (-2.72%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
1.14B
35 days until earnings call
ZNTL
Price
$1.63
Change
+$0.07 (+4.52%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
118.3M
26 days until earnings call
Interact to see
Advertisement

PGEN vs ZNTL

Header iconPGEN vs ZNTL Comparison
Open Charts PGEN vs ZNTLBanner chart's image
Precigen
Price$3.22
Change-$0.09 (-2.72%)
Volume$134.28K
Capitalization1.14B
Zentalis Pharmaceuticals
Price$1.63
Change+$0.07 (+4.52%)
Volume$11.62K
Capitalization118.3M
PGEN vs ZNTL Comparison Chart in %
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PGEN vs. ZNTL commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Hold and ZNTL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (PGEN: $3.22 vs. ZNTL: $1.64)
Brand notoriety: PGEN and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 47% vs. ZNTL: 78%
Market capitalization -- PGEN: $1.14B vs. ZNTL: $118.3M
PGEN [@Biotechnology] is valued at $1.14B. ZNTL’s [@Biotechnology] market capitalization is $118.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both PGEN and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 3 bullish TA indicator(s).

  • PGEN’s TA Score: 4 bullish, 5 bearish.
  • ZNTL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than ZNTL.

Price Growth

PGEN (@Biotechnology) experienced а -3.59% price change this week, while ZNTL (@Biotechnology) price change was +6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

PGEN is expected to report earnings on Nov 12, 2025.

ZNTL is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($1.14B) has a higher market cap than ZNTL($118M). PGEN YTD gains are higher at: 187.500 vs. ZNTL (-45.875). PGEN has higher annual earnings (EBITDA): -121.98M vs. ZNTL (-170.37M). ZNTL has more cash in the bank: 303M vs. PGEN (59.8M). PGEN has less debt than ZNTL: PGEN (5.15M) vs ZNTL (37.7M). ZNTL has higher revenues than PGEN: ZNTL (26.9M) vs PGEN (4.34M).
PGENZNTLPGEN / ZNTL
Capitalization1.14B118M963%
EBITDA-121.98M-170.37M72%
Gain YTD187.500-45.875-409%
P/E RatioN/AN/A-
Revenue4.34M26.9M16%
Total Cash59.8M303M20%
Total Debt5.15M37.7M14%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PGENZNTL
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIGNX12.260.14
+1.16%
Loomis Sayles International Growth N
NREMX26.23N/A
N/A
Neuberger Berman Emerg Mkts Eq R6
TQAAX45.65N/A
N/A
T. Rowe Price Integrated US Sm Gr Eq Adv
CSFZX55.43N/A
N/A
Cohen & Steers Global Realty Z
LGOSX30.75N/A
N/A
Lord Abbett Growth Opportunities R4

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with ARWR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-2.72%
ARWR - PGEN
39%
Loosely correlated
+1.09%
ZNTL - PGEN
39%
Loosely correlated
+5.81%
ARRY - PGEN
39%
Loosely correlated
-2.75%
VCYT - PGEN
39%
Loosely correlated
+1.42%
MRNA - PGEN
38%
Loosely correlated
+2.12%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+5.81%
NGNE - ZNTL
48%
Loosely correlated
+10.06%
IDYA - ZNTL
45%
Loosely correlated
-0.30%
DNLI - ZNTL
43%
Loosely correlated
+5.03%
ORMP - ZNTL
43%
Loosely correlated
-3.63%
SYRE - ZNTL
43%
Loosely correlated
+10.36%
More